Patents Assigned to GLYCOMIRA THERAPEUTICS, INC.
  • Patent number: 11642366
    Abstract: Described herein are methods for preventing a serious health consequence and/or tissue damage in a subject after the subject has been exposed to ionizing radiation and/or chemotherapy. The methods involve administering to the subject a sulfated polysaccharide or the pharmaceutically acceptable salt or ester thereof after the subject has been exposed to ionizing radiation and/or chemotherapy. The methods described herein are most beneficial to cancer patients who suffer from mucositis after exposure to ionizing radiation.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: May 9, 2023
    Assignee: GLYCOMIRA THERAPEUTICS, INC.
    Inventors: Won Yong Lee, Abigail Pulsipher, Thomas P. Kennedy, Justin Rodney Savage, Glenn Prestwich